Body

Global Budget Payment Model lowers medical spending, improves quality

A new study suggests that global budgets for health care, an alternative to the traditional fee-for-service model of reimbursement, can slow the growth of medical spending and improve the quality of care for patients.

Rio+20 sustainability conference gets mixed reviews

Although a walkout by disgruntled activists may have grabbed headlines, the UN Conference on Sustainable Development in Rio de Janeiro last month did produce hundreds of individual commitments from participants with potential for having major impacts. That's the topic of the cover story of this week's Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society, the world's largest scientific society.

Toward new drugs for the human and non-human cells in people

Amid the growing recognition that only a small fraction of the cells and genes in a typical human being are human, scientists are suggesting a revolutionary approach to developing new medicines and treatments to target both the human and non-human components of people. That's the topic of an article, which reviews work relating to this topic from almost 100 studies, in ACS' Journal of Proteome Research.

Widespread exposure to BPA substitute is occurring from cash register receipts, other paper

People are being exposed to higher levels of the substitute for BPA in cash register thermal paper receipts and many of the other products that engendered concerns about the health effects of bisphenol A, according to a new study. Believed to be the first analysis of occurrence of bisphenol S (BPS) in thermal and recycled paper and paper currency, the report appears in ACS' journal Environmental Science & Technology.

Transforming cancer treatment

A Harvard researcher studying the evolution of drug resistance in cancer is predicting that, in a few decades, "many, many cancers could be manageable."

Martin Nowak, a Harvard Professor of Mathematics and of Biology and Director of the Program for Evolutionary Dynamics, is one of several co-authors of a paper, published in Nature, that details how resistance to targeted drug therapy emerges in colorectal cancers, and suggests a new, multi-drug approach to treatment could make many cancers manageable, if not curable, illnesses.

2 proteins offer a 'clearer' way to treat Huntington's disease

In a paper published in the July 11 online issue of Science Translational Medicine, researchers at the University of California, San Diego School of Medicine have identified two key regulatory proteins critical to clearing away misfolded proteins that accumulate and cause the progressive, deadly neurodegeneration of Huntington's disease (HD).

Mayo Clinic finds switch that lets early lung cancer grow unchecked

JACKSONVILLE, Fla. — Cellular change thought to happen only in late-stage cancers to help tumors spread also occurs in early-stage lung cancer as a way to bypass growth controls, say researchers at Mayo Clinic in Florida. The finding, reported in the July 11 issue of Science Translational Medicine, represents a new understanding of the extent of transformation that lung cancer — and likely many other tumor types — undergo early in disease development, the scientists say.

Native American populations descend from 3 key migrations

Scientists have found that Native American populations — from Canada to the southern tip of Chile — arose from at least three migrations, with the majority descended entirely from a single group of First American migrants that crossed over through Beringia, a land bridge between Asia and America that existed during the ice ages, more than 15,000 years ago.

Ions, not particles, make silver toxic to bacteria

HOUSTON – (July 11, 2012) – Rice University researchers have settled a long-standing controversy over the mechanism by which silver nanoparticles, the most widely used nanomaterial in the world, kill bacteria.

Their work comes with a Nietzsche-esque warning: Use enough. If you don't kill them, you make them stronger.

Scientists first to see trafficking of immune cells in beating heart

Blood flow to the heart often is interrupted during a heart attack or cardiac surgery. But when blood flow resumes, the heart may still falter. That's because collateral damage can occur as blood re-enters the heart, potentially slowing recovery and causing future cardiac troubles.

Identifying risky behaviors: The key to HIV prevention

HIV prevention must be better targeted, according to David Holtgrave from Johns Hopkins Bloomberg School of Public Health in the US, and colleagues. Health care professionals need a more detailed analysis and understanding of the interplay between HIV risk behavior, access to treatment and treatment success among those living with HIV. The authors discuss their proposed framework in a study¹ in a special issue of Springer's journal AIDS and Behavior.

Down on the cacao farm: Sloths thrive at chocolate's source

MADISON -- Like many Neotropical fauna, sloths are running out of room to maneuver.

As forests in South and Central America are cleared for agriculture and other human uses, populations of these arboreal leaf eaters, which depend on large trees for both food and refuge, can become isolated and at risk. But one type of sustainable agriculture, shade grown cacao plantations, a source of chocolate, could become critical refuges and bridges between intact forests for the iconic animals.

Cochrane finds no reliable evidence on effectiveness of electric fans in heatwaves

A new Cochrane systematic review of the effects of electric fans in heatwaves has found no high quality evidence to guide future national and international policies. The review outlines the type of study that would help resolve the uncertainty which is spelt out in a podcast and an editorial all published today in The Cochrane Library.

Giving ancient life another chance to evolve

It's a project 500 million years in the making. Only this time, instead of playing on a movie screen in Jurassic Park, it's happening in a lab at the Georgia Institute of Technology.

Using a process called paleo-experimental evolution, Georgia Tech researchers have resurrected a 500-million-year-old gene from bacteria and inserted it into modern-day Escherichia coli(E. coli) bacteria. This bacterium has now been growing for more than 1,000 generations, giving the scientists a front row seat to observe evolution in action.

Scientists develop new strategy to overcome drug-resistant childhood cancer

A new drug combination could offer hope to children with neuroblastoma – one of the deadliest forms of childhood cancer – by boosting the effectiveness of a promising new gene-targeted treatment.

Researchers at The Institute of Cancer Research in London have found a way to overcome the resistance of cancer cells to a drug called crizotinib, which recently showed positive early results in its first trial in children with cancer.